Position in PBYI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,311,092
+$3,134,377 QoQ
Shares Held
1,518,014
+5.7% QoQ
Ownership
2.94%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 160 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 90%
Shared 7%
None 3%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. PBYI ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in PBYI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,311,092 | 1,518,014 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,176,715 | 1,436,106 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,970,636 | 1,339,603 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,753,671 | 1,271,878 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,944,636 | 1,150,040 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,630,441 | 888,663 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,634,466 | 863,760 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,766,618 | 692,792 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,975,484 | 605,977 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,011,952 | 568,293 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,155,136 | 497,722 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,261,113 | 479,511 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,518,986 | 430,308 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,400,093 | 453,105 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $984,612 | 232,769 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $135,812 | 57,305 | Shares | Sole | 2022-11-10 | |
| 2021-09-30 | $296,508 | 42,298 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $296,339 | 32,281 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||